Direct induction by melanoma, prostate cancer and Ewing's sarcoma tumour cells of osteoclast formation by a RANKL-independent mechanism

Direct induction by melanoma, prostate cancer and Ewing's sarcoma tumour cells of osteoclast formation by a RANKL-independent mechanism

Dades bibliogràfiques
Autors principals:	Lau, Y, Sabokbar, A, Giele, H, Gibbons, C, Cerundolo, V, Athanasou, N
Format:	Conference item
Publicat:	2005

Ítems similars

Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma.
per: Lau, Y, et al.
Publicat: (2007)

Ewing sarcoma cells express RANKL and support osteoclastogenesis
per: Taylor, R, et al.
Publicat: (2011)

Ewing sarcoma cells express RANKL and support osteoclastogenesis.
per: Taylor, R, et al.
Publicat: (2011)

Ewing's sarcoma cells promote osteoclast formation
per: Taylor, R, et al.
Publicat: (2010)

Rankl-independent induction of human osteoclast formation and bone resorption by TGF-beta
per: Itonaga, I, et al.
Publicat: (2002)

RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer.
per: Lau, Y, et al.
Publicat: (2007)

Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
per: Sun, S, et al.
Publicat: (2006)

Involvement of RANKL-dependent/independent mechanisms in osteoclast formation in aseptic loosening
per: Sabokbar, A, et al.
Publicat: (2001)

Sarcoma-associated macrophages differentiate into osteoclastic bone-resorbing cells
per: Lau, Y, et al.
Publicat: (2004)

Localized Ewing sarcoma of the tibia.
per: Kashima, T, et al.
Publicat: (2013)

IL-6 induces human osteoclast formation and bone resorption independent of RANK/RANKL interaction
per: Kudo, O, et al.
Publicat: (2001)

Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism.
per: Kudo, O, et al.
Publicat: (2003)

Human osteoclast formation and bone resorption by a mechanism independent of RANK/RANKL: Role of IL-6 and IL-11.
per: Kudo, O, et al.
Publicat: (2001)

Transforming growth factor-beta induces osteoclast formation in the absence of RANKL.
per: Itonaga, I, et al.
Publicat: (2004)

Heterogeneity in Ewing sarcoma
per: Branford White, HA
Publicat: (2014)

RANKL and M-CSF are required for osteoclast differentiation by macrophages in breast cancer
per: Danks, L, et al.
Publicat: (2003)

RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II.
per: Hemingway, F, et al.
Publicat: (2011)

RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II.
per: Hemingway, F, et al.
Publicat: (2011)

Osteoclast differentiation in Paget's disease is hypersensitive to RANKL.
per: Neale, S, et al.
Publicat: (2000)

Metal wear-induced pseudotumour following an endoprosthetic knee replacement for Ewing sarcoma
per: Craig, R, et al.
Publicat: (2017)

Malignant melanoma and bone resorption.
per: Lau, Y, et al.
Publicat: (2006)

Human mesenchymal tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells.
per: Yang, T, et al.
Publicat: (2002)

RANKL-independent osteoclastogenesis in Paget's disease
per: Jones, F, et al.
Publicat: (2008)

Targeted treatment of Ewing sarcomas: Current status
per: Hassan, A
Publicat: (2013)

RANKL plays an important role as activator of osteoclastic bone resorption in acute Charcot osteoarthropathy
per: Petrova, N, et al.
Publicat: (2007)

Human tumour associated macrophages are capable of osteoclastic differentiation and bone resorption
per: Quinn, J, et al.
Publicat: (1997)

Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.
per: Knowles, H, et al.
Publicat: (2010)

Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation.
per: Kudo, O, et al.
Publicat: (2002)

Secreted frizzled-related protein inhibits TNFalpha- or RANKL-dependent osteoclast formation
per: Hausler, K, et al.
Publicat: (2003)

Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
per: Häusler, K, et al.
Publicat: (2004)

Combinatorial drug screening identifies Ewing sarcoma-specific sensitivities
per: Radic-Sarikas, B, et al.
Publicat: (2016)

Effect of corticosteroids on human osteoclast formation and activity.
per: Hirayama, T, et al.
Publicat: (2002)

The effect of corticosteroids on human osteoclast formation and activity
per: Hirayama, T, et al.
Publicat: (2000)

Humoral factors act directly on circulating osteoclast precursors to control osteoclast formation
per: Hirayama, T, et al.
Publicat: (2000)

Formation and isolation of human osteoclasts
per: Kudo, O, et al.
Publicat: (2001)

Malignant neck mass in disguise - atypical presentation of extraskeletal Ewing's sarcoma
per: Poh, Nuan Leng, et al.
Publicat: (2022)

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
per: Jain, A, et al.
Publicat: (2017)

Osteoclast formation in Gorham-Stout disease
per: Hirayama, T, et al.
Publicat: (2000)

Subungual melanoma with osteocartilaginous differentiation.
per: Giele, H, et al.
Publicat: (2003)

Osteoclast-like cells in soft tissue leiomyosarcomas.
per: Gibbons, C, et al.
Publicat: (2010)